Cargando…
The Case for Selective Use of Pre-Operative Chemotherapy for Hepatic Colorectal Metastases: More Is Not Always Better
Autores principales: | Karakousis, Giorgos, Fong, Yuman |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711915/ https://www.ncbi.nlm.nih.gov/pubmed/19513600 http://dx.doi.org/10.1245/s10434-009-0539-9 |
Ejemplares similares
-
Surgical Margins during Hepatic Surgery for Colorectal Liver Metastases: Complete Resection not Millimeters Defines Outcome
por: Pawlik, Timothy M., et al.
Publicado: (2007) -
A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases?
por: de Meijer, V. E., et al.
Publicado: (2008) -
Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
por: Hentzen, Judith E. K. R., et al.
Publicado: (2019) -
Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases
por: van Iersel, Liselot B. J., et al.
Publicado: (2008) -
Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery
por: Hentzen, Judith E. K. R., et al.
Publicado: (2019)